8.7.2013(pharm-anticancer Drugs) 60 Flashcards
Most susceptible atom to Alkylating agents
N7 of guanine
Gompertzian model
Growth fraction peaks when tumor is approx 37% of its maximum size
Mesna
Mercaptoethane sulfonic acid
Mechlorethamine is used in
Hodgkin lymphoma
Adverse effects of cyclophosphamide
Cardiac dysfunction
Pulmonary toxicity
SIADH
Anticancer drugs that cause delayed neutropenia
Nitrsoureas
Adverse effects of busulfan
Adrenal insufficiency
Pulmonary fibrosis
Skin hyperpigmentation
Hyperuricemia
CNS side effects of procarbazine
Hypnosis
Vivid dreams
Drug used for CLL
Chlorambucil
As it spares myelocytes
Cisplatin nephrotoxicity can be prevented by
Chloride diuresis
Doesnot help against ototoxicity
Cisplatin is inactivated by
Aluminium
Drug that can be given to prevent cisplatin induced nephrotoxicity
Amifostine
Electrolyte abnormalities associated with cisplatin
Reduces all ions Hypomagnesimia Hypokalemia Hypophosphatemia Hypocalcemia
Anticancer drugs with strong vesicant properties
Nitrosoureas
Mechlorethamine
Alkylating agent with less chance of secondary leukemia
Cyclophosphamide
Anticancer drugs causing veno occlusive disease
All Alkylating agents in high doses
Alkylating agents causing pulmonary fibrosis
All Alkylating agents
Mechanisms of MTX resistance
Decreased MTX transporter Decreased formation of MTX polyglutamate Increased levels of DHFR due to GENE AMPLIFICATION altered DHFR Increased drug efflux transporter
Enzyme required for activation of MTX and pemetrexed
Folylpolyglutamate synthase
MTX is DOC for
Choriocarcinoma
Pemetrexed is approved for treatment of
Mesothelioma
Citrovorum factor
N10 formyl THF
Rx of MTX toxicity
Citrovorum factor
Alkalinisation of urine
Dialysis
Glucarpidase
Glucarpidase
MTX cleaving enzyme